The structure and function of CD26 in the T‐cell immune response
C Morimoto, SF Schlossman - Immunological reviews, 1998 - Wiley Online Library
CD26 is a widely distributed 110 kD cell‐surface glycoprotein with known dipeptidyl‐
peptidase IV (DPP‐IV) activity in its extracellular domain. This ectoenzyme is capable of …
peptidase IV (DPP‐IV) activity in its extracellular domain. This ectoenzyme is capable of …
Purinergic signalling: pathophysiological roles
MP Abbracchio, G Burnstock - The Japanese Journal of …, 1998 - jstage.jst.go.jp
抄録 In this review, after a summary of the history and current status of the receptors involved
in purinergic signalling, we focus on the distribution and physiological roles of purines and …
in purinergic signalling, we focus on the distribution and physiological roles of purines and …
A new pulsed electric field therapy for melanoma disrupts the tumor's blood supply and causes complete remission without recurrence
R Nuccitelli, X Chen, AG Pakhomov… - … journal of cancer, 2009 - Wiley Online Library
We have discovered a new, ultrafast therapy for treating skin cancer that is extremely
effective with a total electric field exposure time of only 180 μsec. The application of 300 high …
effective with a total electric field exposure time of only 180 μsec. The application of 300 high …
Trophic effects of purines in neurons and glial cells
MP Rathbone, PJ Middlemiss, JW Gysbers… - Progress in …, 1999 - Elsevier
In addition to their well known roles within cells, purine nucleotides such as adenosine 5′
triphosphate (ATP) and guanosine 5′ triphosphate (GTP), nucleosides such as adenosine …
triphosphate (ATP) and guanosine 5′ triphosphate (GTP), nucleosides such as adenosine …
Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells
JT Neary, MP Rathbone, F Cattabeni… - Trends in …, 1996 - cell.com
In addition to their well-established roles as neurotransmitters and neuromodulators,
growing evidence suggests that nucleotides and nucleosides might also act as trophic …
growing evidence suggests that nucleotides and nucleosides might also act as trophic …
A glance at adenosine receptors: novel target for antitumor therapy
Adenosine can be released from a variety of cells throughout the body, as the result of
increased metabolic rates, in concentrations that can have a profound impact on the …
increased metabolic rates, in concentrations that can have a profound impact on the …
Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency
MR Blackburn, SK Datta, RE Kellems - Journal of Biological Chemistry, 1998 - ASBMB
Adenosine deaminase (ADA) deficiency in humans leads to a combined immunodeficiency.
The mechanisms involved in the lymphoid specificity of the disease are not fully understood …
The mechanisms involved in the lymphoid specificity of the disease are not fully understood …
Immunoparalysis after multiple trauma
SK Tschoeke, W Ertel - Injury, 2007 - Elsevier
The immunological sequelae following multiple trauma constitute an ongoing challenge in
critical care management. The overall immune response to multiple trauma is a multilevel …
critical care management. The overall immune response to multiple trauma is a multilevel …
Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor
G Ohana, S Bar‐Yehuda, F Barer… - Journal of cellular …, 2001 - Wiley Online Library
Adenosine is an ubiquitous nucleoside present in all body cells. It is released from
metabolically active or stressed cells and subsequently acts as a regulatory molecule …
metabolically active or stressed cells and subsequently acts as a regulatory molecule …
Induction of apoptosis in HL-60 human Promyelocytic leukemia cells by adenosine A3Receptor agonists
Y Kohno, Y Sei, M Koshiba, HO Kim… - … and biophysical research …, 1996 - Elsevier
The effects of adenosine (ADO) analogs on cells of the human promyelocytic HL-60 line
were examined. ADO A3receptor agonists, N6-(3-iodobenzyl) adenosine-5′-N …
were examined. ADO A3receptor agonists, N6-(3-iodobenzyl) adenosine-5′-N …